✦ LIBER ✦

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

✍ Scribed by Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein Modabbernia; Azad Maroufi; Gholam-Reza Esfandiari; Mehrangiz Naderi; Fariba Ghebleh; Mina Tabrizi; Shams-Ali Rezazadeh

Publisher: Springer
Year: 2010
Tongue: English
Weight: 154 KB
Volume: 213
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-010-2044-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of

Gabapentin in the treatment of fibromyal

Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

Mirtazapine add-on therapy in the treatm

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti

The effects of intravenous doxycycline t

The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

✍ E. William St.Clair; William E. Wilkinson; David S. Pisetsky; Daniel J. Sexton; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Pregabalin for the treatment of fibromya

Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial

✍ Leslie J. Crofford; Michael C. Rowbotham; Philip J. Mease; I. Jon Russell; Rober 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

A double-blind placebo-controlled trial

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

✍ Olivier Vitton; Michael Gendreau; Judy Gendreau; Jay Kranzler; Srinivas G. Rao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Fibromyalgia syndrome is a systemic disorder of widespread pain which is thought to result from abnormal pain processing within the central nervous system. There are no currently approved treatments for this indication. Antidepressants appear, however, to be effective, especially those with an actio